1. Home
  2. KRMD vs CNTN Comparison

KRMD vs CNTN Comparison

Compare KRMD & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

N/A

Current Price

$3.43

Market Cap

146.4M

Sector

Health Care

ML Signal

N/A

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$1.23

Market Cap

153.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRMD
CNTN
Founded
1980
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.4M
153.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRMD
CNTN
Price
$3.43
$1.23
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $6.13
N/A
AVG Volume (30 Days)
173.2K
★ 573.7K
Earning Date
11-10-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
★ 88.10
EPS
★ N/A
N/A
Revenue
★ $41,127,366.00
N/A
Revenue This Year
$17.24
N/A
Revenue Next Year
$16.13
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 22.23
N/A
52 Week Low
$2.86
$1.38
52 Week High
$6.61
$5.27

Technical Indicators

Market Signals
Indicator
KRMD
CNTN
Relative Strength Index (RSI) 51.35 28.83
Support Level $3.00 N/A
Resistance Level $3.41 $2.30
Average True Range (ATR) 0.26 0.18
MACD 0.02 -0.07
Stochastic Oscillator 37.83 0.50

Price Performance

Historical Comparison
KRMD
CNTN

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: